Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.
Trombetti A, Al-Daghri N, Brandi ML, Cannata-Andía JB, Cavalier E, Chandran M, Chaussain C, Cipullo L, Cooper C, Haffner D, Harvengt P, Harvey NC, Javaid MK, Jiwa F, Kanis JA, Laslop A, Laurent MR, Linglart A, Marques A, Mindler GT, Minisola S, Yerro MCP, Rosa MM, Seefried L, Vlaskovska M, Zanchetta MB, Rizzoli R. Trombetti A, et al. Among authors: haffner d. Nat Rev Endocrinol. 2022 Jun;18(6):366-384. doi: 10.1038/s41574-022-00662-x. Epub 2022 Apr 28. Nat Rev Endocrinol. 2022. PMID: 35484227 Review.
Extrarenal effects of FGF23.
Haffner D, Leifheit-Nestler M. Haffner D, et al. Pediatr Nephrol. 2017 May;32(5):753-765. doi: 10.1007/s00467-016-3505-3. Epub 2016 Oct 4. Pediatr Nephrol. 2017. PMID: 27704252 Review.
Paracrine Effects of FGF23 on the Heart.
Leifheit-Nestler M, Haffner D. Leifheit-Nestler M, et al. Among authors: haffner d. Front Endocrinol (Lausanne). 2018 May 28;9:278. doi: 10.3389/fendo.2018.00278. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29892269 Free PMC article. Review.
Phosphate wasting disorders in adults.
Marcucci G, Masi L, Ferrarì S, Haffner D, Javaid MK, Kamenický P, Reginster JY, Rizzoli R, Brandi ML. Marcucci G, et al. Among authors: haffner d. Osteoporos Int. 2018 Nov;29(11):2369-2387. doi: 10.1007/s00198-018-4618-2. Epub 2018 Jul 16. Osteoporos Int. 2018. PMID: 30014155 Review.
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Haffner D, et al. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. Nat Rev Nephrol. 2019. PMID: 31068690 Free PMC article.
FGF23 and Phosphate-Cardiovascular Toxins in CKD.
Vogt I, Haffner D, Leifheit-Nestler M. Vogt I, et al. Among authors: haffner d. Toxins (Basel). 2019 Nov 6;11(11):647. doi: 10.3390/toxins11110647. Toxins (Basel). 2019. PMID: 31698866 Free PMC article. Review.
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description.
Brandi ML, Ariceta G, Beck-Nielsen SS, Boot AM, Briot K, de Lucas Collantes C, Emma F, Giannini S, Haffner D, Keen R, Levtchenko E, Mӓkitie O, Nilsson O, Schnabel D, Tripto-Shkolnik L, Zillikens MC, Liu J, Tudor A, Mughal MZ. Brandi ML, et al. Among authors: haffner d. Ther Adv Chronic Dis. 2022 Sep 5;13:20406223221117471. doi: 10.1177/20406223221117471. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 36082134 Free PMC article.
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.
Ariceta G, Beck-Nielsen SS, Boot AM, Brandi ML, Briot K, de Lucas Collantes C, Emma F, Giannini S, Haffner D, Keen R, Levtchenko E, Mӓkitie O, Mughal MZ, Nilsson O, Schnabel D, Tripto-Shkolnik L, Liu J, Williams A, Wood S, Zillikens MC. Ariceta G, et al. Among authors: haffner d. Orphanet J Rare Dis. 2023 Sep 27;18(1):304. doi: 10.1186/s13023-023-02882-4. Orphanet J Rare Dis. 2023. PMID: 37752558 Free PMC article.
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
M Boot A, Ariceta G, Beck-Nielsen SS, Brandi ML, Briot K, Collantes CL, Giannini S, Haffner D, Keen R, Levtchenko E, Mughal MZ, Makitie O, Nilsson O, Schnabel D, Tripto-Shkolnik L, Zillikens MC, Liu J, Tudor A, Emma F. M Boot A, et al. Among authors: haffner d. Ther Adv Chronic Dis. 2024 May 18;15:20406223241247643. doi: 10.1177/20406223241247643. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 38764445 Free PMC article.
321 results